Frontiers (publisher)

Frontiers (publisher)
Name	Frontiers
Founded	2007
Founders	Henry Markram, Kamila Markram
Country	Switzerland
Headquarters	Lausanne
Distribution	Open access
Publications	Academic journals
Topics	Multidisciplinary science

Frontiers (publisher) is a Switzerland-based open-access academic publisher founded in 2007 by Henry Markram and Kamila Markram. It operates a large portfolio of online journals spanning life sciences, health, physical sciences, social sciences, and humanities, and uses an article processing charge model linked to digital platforms and community peer review. The company has been involved in debates over editorial standards, indexing, and relationships with research institutions, and has grown into a major player alongside PLOS, BioMed Central, and Elsevier in the scholarly publishing landscape.

History

Frontiers was established after the Markrams’ involvement with the Blue Brain Project and the neuroinformatics community; the publisher’s early journals focused on neuroscience and Frontiers in Neuroscience-style collections before expanding into wider disciplines such as Frontiers in Psychology and Frontiers in Immunology. The firm incorporated in Switzerland and opened offices in locations connected to major research hubs like Lausanne, London, New York City, and Beijing. Over time it pursued partnerships with research funders and societies, negotiated article processing charges with universities including University of California campuses and collaborated on publishing initiatives with institutions similar to European Commission open science programs. Growth was accompanied by indexing milestones in services like Web of Science and Scopus, and by strategic hiring from publishers such as Nature Publishing Group and Springer. The company’s timeline intersects with key events in scholarly communication including debates around open access mandates, Plan S-style policies, and the rise of preprint servers exemplified by bioRxiv.

Business model and operations

Frontiers operates primarily on a gold open-access model funded by article processing charges, working with authors funded by agencies such as the National Institutes of Health, the European Research Council, and national research councils. Its platform emphasizes continuous online publishing, editorial boards drawn from academics affiliated with institutions like Harvard University, University of Oxford, Stanford University, and Max Planck Society, and technology infrastructure integrating submission, review, and publishing workflows. The publisher negotiates institutional agreements akin to transformative agreements seen with Wellcome Trust-aligned deals and enters partnerships with university presses and societies comparable to agreements involving American Chemical Society or Royal Society of Chemistry. Frontiers has scaled operations through venture investment and acquisition strategies, aligning with global trends in consolidation exemplified by transactions involving Wiley and Springer Nature.

Editorial policies and peer review

Frontiers employs an editorial model that combines academic editorial boards with an interactive, tiered peer review process managed through its online platform. Editorial leadership often comprises scholars from institutions such as University College London, University of Cambridge, Massachusetts Institute of Technology, and Johns Hopkins University who oversee manuscript handling, while peer reviewers are recruited from networks tied to societies like the Society for Neuroscience and the American Association for the Advancement of Science. Policies cover data availability, conflicts of interest, and ethical oversight including compliance with standards set by organizations such as the Committee on Publication Ethics and regulatory frameworks like the Declaration of Helsinki. The publisher’s model emphasizes acceptance criteria and collaborative revision, a system critiqued and defended in the context of practices used by PLOS Medicine, BMJ, and other major journals.

Publishing portfolio and journals

Frontiers maintains a broad portfolio that includes flagship titles in neuroscience, psychology, immunology, and medicine, comparable in scope to portfolios managed by Nature Portfolio and Cell Press. Its journals host special issues and research topics guest-edited by scholars affiliated with Columbia University, University of Toronto, University of Tokyo, and ETH Zurich, and publish articles across experimental, computational, and translational research streams similar to outputs seen in Science Translational Medicine and The Lancet specialty journals. Frontiers also operates community features, editorial collections, and conference proceedings akin to offerings by IEEE and ACM in engineering fields, and extends into interdisciplinary outlets parallel to PNAS. Indexing by services such as PubMed Central and inclusion in institutional repositories have increased discoverability alongside metrics captured by CrossRef and citation databases like Google Scholar.

Controversies and criticisms

Frontiers has faced controversies over perceived editorial practices, article retractions, and relationships with editorial board members, echoing disputes seen at other publishers such as Springer Nature and Wiley-Blackwell. Critics have raised concerns in outlets including investigations by media organizations and commentary referencing standards promoted by COPE, alleging instances of inadequate peer review or conflicts of interest; defenders point to corrections, retractions, and policy changes analogous to responses from Elsevier after high-profile cases. Debates have also involved indexing decisions by Web of Science and funding policies by agencies like the European Research Council, prompting discussions about transparency, governance, and the balance between open access expansion and quality assurance. The company has taken remedial steps, updating editorial policies and enhancing reviewer training in ways similar to reforms undertaken by The Royal Society and other learned societies.

Impact, metrics, and reception

Frontiers’ impact is measured through article-level metrics, citation counts in Scopus and Web of Science, and alternative metrics tracked by services like Altmetric. Reception among academics varies: proponents cite rapid dissemination and article-level engagement comparable to successes of PLOS ONE and eLife, while critics compare its practices to contested models in scholarly publishing debates involving Plan S implementation and funder mandates from bodies like the Wellcome Trust and Horizon Europe. Institutional subscriptions, transformative agreements, and the publisher’s presence in major university library collections including those at Oxford University and Yale University reflect its integration into global research infrastructure, even as scrutiny from oversight bodies and scholarly communities continues to shape its evolution.

Category:Academic publishing companies Category:Open access publishers Category:Publishing companies of Switzerland